Nigeria has recorded a landmark medical achievement as the first locally available cure for sickle cell disease becomes a reality through a groundbreaking partnership between the Sickle Cell Foundation Nigeria (SCFN) and the Lagos University Teaching Hospital (LUTH).
The newly established LUTH–SCFN Bone Marrow Transplant (BMT) Centre, officially announced in September 2024 and fully operational throughout 2025, is the first dedicated sickle cell bone marrow transplant facility in West Africa. It delivers what experts describe as the only proven medical cure for sickle cell disorder, providing patients with a safe, accessible, and affordable life-saving option within Nigeria.
A Cure Now Within Reach
Bone marrow transplantation—long recognised globally as the definitive cure for sickle cell disease—has historically been out of reach for most Nigerian families due to the high cost of travelling abroad to countries such as India, the U.S., and the U.K.
With the new facility at LUTH, patients who have a matched donor (typically a sibling) can now undergo transplantation locally. According to medical specialists leading the programme, successful transplants have already been performed, with recipients no longer experiencing sickle cell crises and officially declared cured after one year of clinical follow-up.
Why This Matters for Nigeria
Nigeria accounts for the highest burden of sickle cell disease globally, with an estimated 150,000 babies born annually with the condition. For decades, families relied on lifelong management, limited treatment options, and the hope of fundraising to access care abroad.
The availability of a local cure marks a historic shift in the fight against the disorder, offering renewed hope to thousands of households.
A Practical Alternative to Gene Therapy
While cutting-edge gene-editing treatments like Casgevy (CRISPR-based gene therapy) made international headlines after U.S. and U.K. approval, these therapies remain unavailable and financially inaccessible in Nigeria.
The LUTH–SCFN bone marrow transplant programme therefore offers the most realistic, proven, and affordable path to cure for eligible Nigerian patients, including both children and adults with severe sickle cell complications.
Open for Screening and Evaluation
SCFN and LUTH have confirmed that the programme is now fully open to the public. Interested individuals can visit the Sickle Cell Foundation Nigeria office in Lagos or the LUTH BMT Centre for donor matching, screening, and further medical evaluation.
A New Era for Sickle Cell Care
Health sector stakeholders describe this milestone as “a transformative moment” for Nigeria’s healthcare system and a powerful step toward reducing the country’s sickle cell burden.
As the bone marrow transplant centre begins to serve more families, Nigeria stands on the brink of rewriting the story of sickle cell disorder—from lifelong struggle to permanent cure.
